Applied Therapeutics, Inc. Current Assets
Applied Therapeutics, Inc. had Current Assets of $31.65 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-11-13
- 2025-09-30: Assets, Current $31.65M.
- 2025-06-30: Assets, Current $34.51M.
- 2025-03-31: Assets, Current $53.97M.
- 2024-12-31: Assets, Current $83.65M.
| Period end | Assets, Current |
|---|---|
| 2025-09-30 | $31.65M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $34.51M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $53.97M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $83.65M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $104.60M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $127.57M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $150.91M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $54.39M 10-K · filed 2025-04-15 |
| 2023-09-30 | $44.49M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $42.82M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $29.06M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $37.31M 10-K · filed 2024-03-06 |
| 2022-09-30 | $55.51M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $76.90M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $63.56M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $88.39M 10-K · filed 2023-03-23 |
| 2021-09-30 | $116.94M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $135.25M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $154.41M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $102.59M 10-K · filed 2022-03-10 |
| 2020-09-30 | $122.89M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $148.52M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $163.74M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $46.16M 10-K · filed 2021-03-18 |
| 2019-09-30 | $37.03M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $46.78M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $16.87M 10-Q · filed 2019-06-21 |
| 2018-12-31 | $20.25M 10-K · filed 2020-03-13 |